135 related articles for article (PubMed ID: 27720203)
41. Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx.
Levendag PC; Schmitz PI; Jansen PP; Eijkenboom WM; Visser AG; Kolkman-Deurloo IK; Sipkema D; Visch LL; Senan S
J Clin Oncol; 1998 Jun; 16(6):2213-20. PubMed ID: 9626223
[TBL] [Abstract][Full Text] [Related]
42. [Definitive treatment of anal canal carcinoma with radiotherapy: adverse impact of a pre-radiation resection. A retrospective study of 57 patients treated with curative intent].
Coquard R; Cenni JC; Artru P; Chalabreysse P; Queneau PE; Taieb S; Alessio A; Lledo G
Cancer Radiother; 2009 Dec; 13(8):715-20. PubMed ID: 19854092
[TBL] [Abstract][Full Text] [Related]
43. Parametrial boosting in locally advanced cervical cancer: combined intracavitary/interstitial brachytherapy vs. intracavitary brachytherapy plus external beam radiotherapy.
Mohamed S; Kallehauge J; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2015; 14(1):23-8. PubMed ID: 25455382
[TBL] [Abstract][Full Text] [Related]
44. High-dose-rate brachytherapy and external-beam radiotherapy for hormone-naïve low- and intermediate-risk prostate cancer: a 7-year experience.
Aluwini S; van Rooij PH; Kirkels WJ; Jansen PP; Praag JO; Bangma CH; Kolkman-Deurloo IK
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1480-5. PubMed ID: 22285661
[TBL] [Abstract][Full Text] [Related]
45. New method of radiotherapy for anal cancer with three-dimensional tumor reconstruction based on endoanal ultrasound and ultrasound-guided afterloading therapy.
Löhnert M; Doniec JM; Kovács G; Schröder J; Dohrmann P
Dis Colon Rectum; 1998 Feb; 41(2):169-76. PubMed ID: 9556240
[TBL] [Abstract][Full Text] [Related]
46. Concomitant External-beam Irradiation and Chemotherapy Followed by High-dose Rate Brachytherapy Boost in the Treatment of Squamous Cell Carcinoma of the Vagina: A Single-Center Retrospective Study.
Laliscia C; Fabrini MG; Delishaj D; Coraggio G; Morganti R; Tana R; Paiar F; Gadducci A
Anticancer Res; 2016 Apr; 36(4):1885-9. PubMed ID: 27069175
[TBL] [Abstract][Full Text] [Related]
47. Partial breast re-irradiation for local recurrence of breast carcinoma: Benefit and long term side effects.
Sedlmayer F; Zehentmayr F; Fastner G
Breast; 2013 Aug; 22 Suppl 2():S141-6. PubMed ID: 24074775
[TBL] [Abstract][Full Text] [Related]
48. Radiotherapy in the treatment of patients with unresectable extrahepatic cholangiocarcinoma.
Ghafoori AP; Nelson JW; Willett CG; Chino J; Tyler DS; Hurwitz HI; Uronis HE; Morse MA; Clough RW; Czito BG
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):654-9. PubMed ID: 20864265
[TBL] [Abstract][Full Text] [Related]
49. Long-term outcomes with high-dose-rate brachytherapy for the management of base of tongue cancer.
Takácsi-Nagy Z; Oberna F; Koltai P; Hitre E; Major T; Fodor J; Polgár C
Brachytherapy; 2013; 12(6):535-41. PubMed ID: 23988507
[TBL] [Abstract][Full Text] [Related]
50. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
51. Toward four-dimensional image-guided adaptive brachytherapy in locally recurrent endometrial cancer.
Fokdal L; Ørtoft G; Hansen ES; Røhl L; Pedersen EM; Tanderup K; Lindegaard JC
Brachytherapy; 2014; 13(6):554-61. PubMed ID: 25056640
[TBL] [Abstract][Full Text] [Related]
52. High-dose-rate interstitial brachytherapy for gynecologic malignancies.
Beriwal S; Bhatnagar A; Heron DE; Selvaraj R; Mogus R; Kim H; Gerszten K; Kelley J; Edwards RP
Brachytherapy; 2006; 5(4):218-22. PubMed ID: 17118313
[TBL] [Abstract][Full Text] [Related]
53. Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal.
Eng C; Chang GJ; You YN; Das P; Xing Y; Delclos M; Wolff RA; Rodriguez-Bigas MA; Skibber J; Ohinata A; Gould S; Phillips J; Crane CH
Cancer; 2013 Nov; 119(21):3769-75. PubMed ID: 24037775
[TBL] [Abstract][Full Text] [Related]
54. Can increasing the dose of radiation by HDR brachytherapy boost following pre operative chemoradiotherapy for advanced rectal cancer improve surgical outcomes?
Sun Myint A; Mukhopadhyay T; Ramani VS; Perkins K; Snee AJ; Jelley F; Wong H; Lee CD
Colorectal Dis; 2010 Aug; 12 Suppl 2():30-6. PubMed ID: 20618365
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of a 36 Gy elective node irradiation dose in anal cancer.
Lépinoy A; Lescut N; Puyraveau M; Caubet M; Boustani J; Lakkis Z; Fantoli M; Buffet-Miny J; Kim S; Bednarek C; Maingon P; Créhange G; Bosset JF
Radiother Oncol; 2015 Aug; 116(2):197-201. PubMed ID: 26277433
[TBL] [Abstract][Full Text] [Related]
56. [The prognostic factors following the simultaneous radiochemotherapy of anal canal carcinoma in a multicenter series of 139 patients].
Grabenbauer GG; Panzer M; Hültenschmidt B; Döker R; Huber K; Kuhne-Velte HJ; Hutter M; Rühl U; Budach V; Wendt T
Strahlenther Onkol; 1994 Jul; 170(7):391-9. PubMed ID: 8052938
[TBL] [Abstract][Full Text] [Related]
57. Treatment of T1-T2 rectal tumors by contact therapy and interstitial brachytherapy.
Coatmeur O; Truc G; Barillot I; Horiot JC; Maingon P
Radiother Oncol; 2004 Feb; 70(2):177-82. PubMed ID: 15028405
[TBL] [Abstract][Full Text] [Related]
58. Pulsed-dose-rate brachytherapy for uterine cervix carcinoma: 10 years of experience with 226 patients at a single institution.
Petit A; Floquet A; Lasbareilles O; Stoeckle E; Chemin A; Kind M; Guyon F; Brouste V; Pigneux J; Thomas L
Brachytherapy; 2013; 12(6):542-9. PubMed ID: 23880416
[TBL] [Abstract][Full Text] [Related]
59. Under-utilisation of high-dose-rate brachytherapy boost in men with intermediate-high risk prostate cancer treated with external beam radiotherapy.
Ong WL; Evans SM; Millar JL
J Med Imaging Radiat Oncol; 2018 Apr; 62(2):256-261. PubMed ID: 29271056
[TBL] [Abstract][Full Text] [Related]
60. [Use of high-energy intraluminal brachytherapy in radio- and radiochemotherapy for anal cancer].
Tarasov VA; Larin IA; Sharov IuK; Bogdanovich AS; Litvinov AIu
Vopr Onkol; 2010; 56(3):307-11. PubMed ID: 20804052
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
